247 related articles for article (PubMed ID: 21617848)
1. Role of periostin in cancer progression and metastasis: inhibition of breast cancer progression and metastasis by anti-periostin antibody in a murine model.
Kyutoku M; Taniyama Y; Katsuragi N; Shimizu H; Kunugiza Y; Iekushi K; Koibuchi N; Sanada F; Oshita Y; Morishita R
Int J Mol Med; 2011 Aug; 28(2):181-6. PubMed ID: 21617848
[TBL] [Abstract][Full Text] [Related]
2. Periostin promotes ovarian cancer angiogenesis and metastasis.
Zhu M; Fejzo MS; Anderson L; Dering J; Ginther C; Ramos L; Gasson JC; Karlan BY; Slamon DJ
Gynecol Oncol; 2010 Nov; 119(2):337-44. PubMed ID: 20688362
[TBL] [Abstract][Full Text] [Related]
3. Identification of a novel cell binding site of periostin involved in tumour growth.
Orecchia P; Conte R; Balza E; Castellani P; Borsi L; Zardi L; Mingari MC; Carnemolla B
Eur J Cancer; 2011 Sep; 47(14):2221-9. PubMed ID: 21605971
[TBL] [Abstract][Full Text] [Related]
4. The neural cell adhesion molecule is involved in the metastatic capacity in a murine model of lung cancer.
Campodónico PB; de Kier Joffé ED; Urtreger AJ; Lauria LS; Lastiri JM; Puricelli LI; Todaro LB
Mol Carcinog; 2010 Apr; 49(4):386-97. PubMed ID: 20191608
[TBL] [Abstract][Full Text] [Related]
5. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer.
Zhang H; Stephens LC; Kumar R
Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of adhesion, invasion, and metastasis by antibodies targeting CEACAM6 (NCA-90) and CEACAM5 (Carcinoembryonic Antigen).
Blumenthal RD; Hansen HJ; Goldenberg DM
Cancer Res; 2005 Oct; 65(19):8809-17. PubMed ID: 16204051
[TBL] [Abstract][Full Text] [Related]
7. Genomic analysis of a spontaneous model of breast cancer metastasis to bone reveals a role for the extracellular matrix.
Eckhardt BL; Parker BS; van Laar RK; Restall CM; Natoli AL; Tavaria MD; Stanley KL; Sloan EK; Moseley JM; Anderson RL
Mol Cancer Res; 2005 Jan; 3(1):1-13. PubMed ID: 15671244
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
9. Anti-flt1 peptide, a vascular endothelial growth factor receptor 1-specific hexapeptide, inhibits tumor growth and metastasis.
Bae DG; Kim TD; Li G; Yoon WH; Chae CB
Clin Cancer Res; 2005 Apr; 11(7):2651-61. PubMed ID: 15814646
[TBL] [Abstract][Full Text] [Related]
10. The serine protease inhibitor protease nexin-1 controls mammary cancer metastasis through LRP-1-mediated MMP-9 expression.
Fayard B; Bianchi F; Dey J; Moreno E; Djaffer S; Hynes NE; Monard D
Cancer Res; 2009 Jul; 69(14):5690-8. PubMed ID: 19584287
[TBL] [Abstract][Full Text] [Related]
11. Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IR in vitro and in vivo.
Kurio N; Shimo T; Fukazawa T; Takaoka M; Okui T; Hassan NM; Honami T; Hatakeyama S; Ikeda M; Naomoto Y; Sasaki A
Exp Cell Res; 2011 May; 317(8):1134-46. PubMed ID: 21338601
[TBL] [Abstract][Full Text] [Related]
12. Antitumor and antimetastatic activities of chloroquine diphosphate in a murine model of breast cancer.
Jiang PD; Zhao YL; Deng XQ; Mao YQ; Shi W; Tang QQ; Li ZG; Zheng YZ; Yang SY; Wei YQ
Biomed Pharmacother; 2010 Nov; 64(9):609-14. PubMed ID: 20888174
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic potential of hyaluronan oligosaccharides for bone metastasis of breast cancer.
Urakawa H; Nishida Y; Knudson W; Knudson CB; Arai E; Kozawa E; Futamura N; Wasa J; Ishiguro N
J Orthop Res; 2012 Apr; 30(4):662-72. PubMed ID: 21913222
[TBL] [Abstract][Full Text] [Related]
14. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
[TBL] [Abstract][Full Text] [Related]
15. Exon-based clustering of murine breast tumor transcriptomes reveals alternative exons whose expression is associated with metastasis.
Dutertre M; Lacroix-Triki M; Driouch K; de la Grange P; Gratadou L; Beck S; Millevoi S; Tazi J; Lidereau R; Vagner S; Auboeuf D
Cancer Res; 2010 Feb; 70(3):896-905. PubMed ID: 20103641
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CCR4 promotes tumor growth and lung metastasis in breast cancer.
Li JY; Ou ZL; Yu SJ; Gu XL; Yang C; Chen AX; Di GH; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2012 Feb; 131(3):837-48. PubMed ID: 21479551
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of noggin inhibits BMP-mediated growth of osteolytic prostate cancer lesions.
Feeley BT; Krenek L; Liu N; Hsu WK; Gamradt SC; Schwarz EM; Huard J; Lieberman JR
Bone; 2006 Feb; 38(2):154-66. PubMed ID: 16126463
[TBL] [Abstract][Full Text] [Related]
18. Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer.
Ben QW; Jin XL; Liu J; Cai X; Yuan F; Yuan YZ
Oncol Rep; 2011 Mar; 25(3):709-16. PubMed ID: 21225237
[TBL] [Abstract][Full Text] [Related]
19. Intrinsic focal adhesion kinase activity controls orthotopic breast carcinoma metastasis via the regulation of urokinase plasminogen activator expression in a syngeneic tumor model.
Mitra SK; Lim ST; Chi A; Schlaepfer DD
Oncogene; 2006 Jul; 25(32):4429-40. PubMed ID: 16547501
[TBL] [Abstract][Full Text] [Related]
20. Bone morphogenetic protein 7 in the development and treatment of bone metastases from breast cancer.
Buijs JT; Henriquez NV; van Overveld PG; van der Horst G; Que I; Schwaninger R; Rentsch C; Ten Dijke P; Cleton-Jansen AM; Driouch K; Lidereau R; Bachelier R; Vukicevic S; Clézardin P; Papapoulos SE; Cecchini MG; Löwik CW; van der Pluijm G
Cancer Res; 2007 Sep; 67(18):8742-51. PubMed ID: 17875715
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
